New hope for tough blood cancers? experimental drug enters human testing
Disease control
Terminated
This study tested a new drug called NMS-03592088 in adults whose acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML) had returned or did not respond to standard treatments. The main goals were to find a safe dose and see if the drug could help control the cance…
Phase: PHASE1, PHASE2 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC